3SBio Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Jing Lou
Chief executive officer
CN¥8.1m
Total compensation
| CEO salary percentage | 29.28% |
| CEO tenure | 19.4yrs |
| CEO ownership | 2.3% |
| Management average tenure | 4.5yrs |
| Board average tenure | 7.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2025 | n/a | n/a | CN¥2b |
| Mar 31 2025 | n/a | n/a | CN¥2b |
| Dec 31 2024 | CN¥8m | CN¥2m | CN¥2b |
| Sep 30 2024 | n/a | n/a | CN¥2b |
| Jun 30 2024 | n/a | n/a | CN¥2b |
| Mar 31 2024 | n/a | n/a | CN¥2b |
| Dec 31 2023 | CN¥5m | CN¥1m | CN¥2b |
| Sep 30 2023 | n/a | n/a | CN¥2b |
| Jun 30 2023 | n/a | n/a | CN¥2b |
| Mar 31 2023 | n/a | n/a | CN¥2b |
| Dec 31 2022 | CN¥4m | CN¥1m | CN¥2b |
| Sep 30 2022 | n/a | n/a | CN¥2b |
| Jun 30 2022 | n/a | n/a | CN¥2b |
| Mar 31 2022 | n/a | n/a | CN¥2b |
| Dec 31 2021 | CN¥4m | CN¥932k | CN¥2b |
| Sep 30 2021 | n/a | n/a | CN¥1b |
| Jun 30 2021 | n/a | n/a | CN¥1b |
| Mar 31 2021 | n/a | n/a | CN¥934m |
| Dec 31 2020 | CN¥4m | CN¥432k | CN¥836m |
| Sep 30 2020 | n/a | n/a | CN¥1b |
| Jun 30 2020 | n/a | n/a | CN¥1b |
| Mar 31 2020 | n/a | n/a | CN¥1b |
| Dec 31 2019 | CN¥194m | CN¥432k | CN¥974m |
Compensation vs Market: Jing's total compensation ($USD1.17M) is below average for companies of similar size in the US market ($USD7.70M).
Compensation vs Earnings: Jing's compensation has increased by more than 20% in the past year.
CEO
Jing Lou (62 yo)
Dr. Jing Lou, M.D., Ph.D. is a Co-Founder of 3SBio Inc. and has been its Executive Chairman of the Board since April 1, 2012 and also serves as its Chief Executive Officer and President. Dr. Lou is Directo...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | no data | CN¥8.12m | 2.26% $ 170.7m | |
| Senior VP & Executive Director | no data | CN¥1.46m | 0.98% $ 73.7m | |
| Chief Financial Officer | 2.6yrs | no data | no data | |
| Company Secretary | 4yrs | no data | no data | |
| General Manager of Sunshine Guojian Pharmaceutical (Shanghai) Co. | 2.4yrs | no data | no data | |
| General Manager of Shenzhen Sciprogen Bio-pharmaceutical Technology Co. | 11.1yrs | no data | no data | |
| General Manager of Shenyang Sunshine Pharmaceutical Co. | 5.1yrs | no data | no data | |
| General Manager of Zhejiang Sunshine Mandi Pharmaceutical Co. | 5.1yrs | no data | no data | |
| Executive of IR | no data | no data | no data |
Experienced Management: TRSB.F's management team is considered experienced (4.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 19.4yrs | CN¥8.12m | 2.26% $ 170.7m | |
| Senior VP & Executive Director | 13.7yrs | CN¥1.46m | 0.98% $ 73.7m | |
| Independent Non-Executive Director | 10.7yrs | CN¥274.00k | no data | |
| Non-Executive Director | 1.7yrs | CN¥406.00k | 0.49% $ 37.2m | |
| Independent Non-Executive Director | 4.7yrs | CN¥274.00k | no data | |
| Independent Non-Executive Director | 4.1yrs | CN¥274.00k | no data |
Experienced Board: TRSB.F's board of directors are considered experienced (7.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/19 14:51 |
| End of Day Share Price | 2026/02/19 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
3SBio Inc. is covered by 36 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bo Yu | China International Capital Corporation Limited |
| Zhuhong Chen | China Merchants Securities (HK) Co., Ltd |
| Fangqi Dai | China Merchants Securities (HK) Co., Ltd |